DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE

DEFINITIVE CONTRACT won by CERAMEDIX HOLDING, LLC · work in NEW YORK, NY
$4,223,612
RecipientCERAMEDIX HOLDING, LLC UEI JLZSJRJVKJ49
Award ID75N93023C00015
Award amount$4,223,612
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN12
Set-asideUnrestricted
Start dateJul 1, 2023
End dateJun 30, 2027
Place of performanceNEW YORK, NY
Record updatedJul 20, 2026

View the official award record

More awards won by CERAMEDIX HOLDING, LLC

JW190496 FY19 NEW START
Department of Defense · $4,496,897 · Sep 28, 2020
DEVELOPMENT OF RADIATION/NUCLEAR MEDICAL COUNTERMEASURES (MCMS) AND BIODOSIMETRY DEVICES. 7-1/2026 TO 6/30/2026. DAP-NCAP-00000073.
Department of Health and Human Services · $1,500,000 · Jul 1, 2026

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids